【white marble chips for landscaping ideas】Why Is Idexx (IDXX) Down 10.3% Since Last Earnings Report?
It has been about a month since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 10.3% in that time frame,white marble chips for landscaping ideas underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Idexx due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
IDEXX Q4 Earnings Top Estimates , Revenues Grow Y/Y
IDEXX Laboratories, Inc
.
posted fourth-quarter 2019 earnings per share of $1.04, reflecting a 6.1% year-over-year rise. The figure surpassed the Zacks Consensus Estimate by 14.3%. Comparable-constant-currency earnings growth was 17%, which excludes the impact of CEO transition charges of 14 cents per share.
For 2019, earnings came in at $4.89, up 14.8% (up 21% at comparable constant currency basis) from the year-ago tally. The figure surpassed the Zacks Consensus Estimate by 2.7%.
Revenues in Detail
Fourth-quarter revenues grew 10.2% year over year to $605.4 million. The metric also beat the Zacks Consensus Estimate by 0.9%. The year-over-year upside was primarily driven by strong global gains in Companion Animal Group (“CAG”) Diagnostics’ recurring revenues.
For 2019, revenues totaled $2.41 billion, up 9% on a reported basis and 10% on an organic basis. The figure surpassed the Zacks Consensus Estimate by 0.4%.
Segmental Analysis
IDEXX derives revenues from four operating segments — CAG; Water; Livestock, Poultry and Dairy (LPD); and Other. In the fourth quarter, CAG revenues rose 11% (up 11% organically) year over year to $529.8 million. The Water segment’s revenues were up 9% (up 10% organically) year over year to $32.87 million. LPD revenues rose 8% (up 10% organically) to $36.7 million. Revenues at the Other segment grew to $6.1 million.
Margins
Gross profit in the fourth quarter rose 10.3% to $331.1 million despite a 10.1% rise in cost of revenues to $274.3 million. Accordingly, gross margin expanded 2 basis points (bps) to 54.7%.
Sales and marketing expenses rose 10.2% to $105.7 million, while general and administrative expenses moved up 26.6% to $74.7 million. Additionally, research and development expenses rose 16.7% to $35.2 million. Operating margin in the quarter contracted 190 bps to 19.1%.
Financial Position
IDEXX exited fiscal 2019 with cash and cash equivalents of $90.3 million compared with $123.8 million at the end of 2018. Net cash provided by operating activities at the end of fiscal 2019 was $459.2 million compared with $400.1 million at the end of 2018.
2020 Outlook
IDEXX has raised its revenue guidance for 2020 to a band of $2.62-2.65 billion, indicating organic and reported revenue growth of 9-10.5%. The Zacks Consensus Estimate for revenues of $2.64 billion falls within the company’s guided range.
Meanwhile, the earnings projection has been raised by 12 cents to the band of $5.42 - $5.58, suggesting annualized growth of 13-16% at CER The Zacks Consensus Estimate for earnings stands at $5.42, within the company’s projected range.
Story continues
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates review.
VGM Scores
Currently, Idexx has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of this revision has been net zero. It comes with little surprise Idexx has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
View comments
相关文章
Callon Petroleum Climbs 4% As 3Q Sales Surge 74%; Street Sticks To Hold
Shares of Callon Petroleum are rising 4.4% in Tuesday's pre-market trading after the natural gas com2024-09-29BRIEF-Malaysia Airports Holdings Announces Termination Of Agreement For Proposed Disposal
Jan 2 (Reuters) - Malaysia Airports Holdings Bhd:* SPA FOR PROPOSED DISPOSAL OF CO'S ENTIRE 11% STAK2024-09-29Is Primoris Services Corporation (NASDAQ:PRIM) Expensive For A Reason? A Look At The Intrinsic Value
In this article I am going to calculate the intrinsic value of Primoris Services Corporation (NASDAQ2024-09-29Drill, China, drill: State majors step on the gas after Xi calls for energy security
By Chen Aizhu and Meng MengSINGAPORE/BEIJING (Reuters) - China's state energy giants are set to rais2024-09-29Where Do Hedge Funds Stand On FS Bancorp, Inc. (FSBW)?
In this article we will check out the progression of hedge fund sentiment towards FS Bancorp, Inc. (2024-09-29BRIEF-Healius Ltd Says Received Unsolicited Proposal From Jangho Hong Kong Ltd
Jan 3 (Reuters) - Healius Ltd:* RECEIVED AN UNSOLICITED AND HIGHLY CONDITIONAL PROPOSAL FROM JANGHO2024-09-29
最新评论